CERVIDIL

This brand name is authorized in Canada, New Zealand, Poland, Singapore, United States

Active ingredients

The drug CERVIDIL contains one active pharmaceutical ingredient (API):

1 Dinoprostone UNII K7Q1JQR04M - DINOPROSTONE

Read about Dinoprostone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CERVIDIL Vaginal insert	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G02AD02	Dinoprostone	G Genito urinary system and sex hormones → G02 Other gynecologicals → G02A Oxytocics → G02AD Prostaglandins
Discover more medicines within G02AD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02231047
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 9951
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100404540
Country: SG	Health Sciences Authority	Identifier(s): 13982P
Country: US	FDA, National Drug Code	Identifier(s): 55566-2800